{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:35:59Z","timestamp":1788536159667,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Guiyang high level innovative youth health talent project fund","award":["2021-SWJJ-010"],"award-info":[{"award-number":["2021-SWJJ-010"]}]},{"name":"the Science and Technology Fund Project of the Health Commission of Guizhou Province","award":["gzwkj2025-210"],"award-info":[{"award-number":["gzwkj2025-210"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Sepsis can trigger life-threatening atypical hemolytic uremic syndrome (aHUS) through dysregulated complement activation. Diagnosis is challenging due to overlapping features with septic shock, often leading to delayed recognition and high mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 23-year-old female with chronic kidney disease presented with a 3-day history of productive cough, fever, and progressive dyspnea, which rapidly escalated to respiratory failure, anuria, and coma within 24 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Laboratory findings confirmed thrombotic microangiopathy (hemoglobin 57\u2009g\/L, platelets 69\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, schistocytes 0.3%, lactate dehydrogenase [LDH] 469 U\/L) and acute kidney injury (creatinine 535 \u00b5mol\/L). The diagnosis of complement-mediated aHUS was established by markedly elevated soluble C5b-9 (sC5b-9) (578\u2009ng\/mL) with preserved a disintegrin and metalloproteinase with thrombospondin motifs 13 activity (89%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Critical care included mechanical ventilation and continuous renal replacement therapy. Specific aHUS therapy comprised plasma exchange (10 sessions) and complement blockade with eculizumab (900\u2009mg weekly for 4 weeks, then 1200\u2009mg every 2 weeks), accompanied by meningococcal prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>\n                      By day 31, hematologic and renal parameters improved (platelets 72\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, LDH 273 U\/L, creatinine 151 \u00b5mol\/L). By day 51, complement activity normalized (sC5b-9 261\u2009ng\/mL, a 54.8% reduction), with full hematologic recovery (platelets 198\u2005\u00d7\u200510\n                      <jats:sup>9<\/jats:sup>\n                      \/L, LDH 171 U\/L), renal function near baseline (creatinine 96 \u00b5mol\/L), and resolution of hemolysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>In sepsis with persistent thrombocytopenia despite infection control, urgent sC5b-9 testing is critical to diagnose aHUS. Eculizumab, combined with supportive continuous renal replacement therapy and plasma exchange, can effectively reverse multi-organ failure even during active bacteremia, with serial sC5b-9 monitoring serving as a key biomarker for guiding therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047281","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:25Z","timestamp":1769191345000},"page":"e47281","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Salvaging sepsis-associated atypical hemolytic uremic syndrome with terminal complement blockade: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2369-1719","authenticated-orcid":false,"given":"Yuyang","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6303-2059","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second People\u2019s Hospital of Guiyang (Jinyang Hospital)\/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/ajh.26854","article-title":"Complement-driven hemolytic uremic syndrome.","volume":"98","author":"Leon","year":"2023","journal-title":"Am J Hematol"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaci.2025.05.010","article-title":"Atypical haemolytic uraemic syndrome.","volume":"156","author":"Walsh","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.kint.2024.12.016","article-title":"The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndrome.","volume":"107","author":"Smith-Jackson","year":"2025","journal-title":"Kidney Int"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome.","volume":"152","author":"Azoulay","year":"2017","journal-title":"Chest"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"1264310","DOI":"10.3389\/fmed.2023.1264310","article-title":"Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults.","volume":"10","author":"\u00c1vila","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/SHK.0000000000001504","article-title":"Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation.","volume":"54","author":"Abe","year":"2020","journal-title":"Shock"},{"key":"R8-20260610","first-page":"396","article-title":"Multidisciplinary consensus on the diagnosis and treatment of atypical hemolytic uremic syndrome (2025 version).","volume":"64","author":"Minghui","year":"2025","journal-title":"Chin J Int Med"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4274\/tjh.2016.0359","article-title":"The clinical significance of schistocytes: a prospective evaluation of the international council for standardization in hematology schistocyte guidelines.","volume":"34","author":"Schapkaitz","year":"2017","journal-title":"Turk J Haematol"},{"key":"R10-20260610","first-page":"734","article-title":"Diagnosis and treatment of atypical hemolytic uremic syndrome: a case report and literature review.","volume":"23","author":"Haiyan","year":"2024","journal-title":"Chin J Gen Pract"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13054-023-04344-6","article-title":"Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity.","volume":"27","author":"de Nooijer","year":"2023","journal-title":"Crit Care"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome.","volume":"400","author":"Michael","year":"2022","journal-title":"Lancet"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/asheducation-2016.1.217","article-title":"Atypical hemolytic uremic syndrome.","volume":"2016","author":"Afshar-Kharghan","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy.","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R18-20260610","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome.","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","article-title":"Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis.","volume":"29","author":"Benamu","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood.2022018833","article-title":"Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.","volume":"142","author":"Brocklebank","year":"2023","journal-title":"Blood"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-019-1314-1","article-title":"Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.","volume":"20","author":"Menne","year":"2019","journal-title":"BMC Nephrol"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney.","volume":"13","author":"Brocklebank","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy.","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura.","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/AGINGADV.AGINGADV-D-24-00024","article-title":"The impact of aging on outcomes in acute respiratory distress syndrome: a multicenter cohort study.","volume":"1","author":"Huang","year":"2024","journal-title":"Aging Adv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:03:14Z","timestamp":1781085794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047281","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-06-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}